Process of programmed cell death
ATP-dependent
Activate caspases (cytosolic proteases) -> cellular breakdown including:
* cell shrinkage
* chromatin condensation
* membrane blebbing
* formation of apoptotic bodies, which are then phagocytosed
When fat dies and fatty acids are released, they combine with Ca to produce chalky white deposits
Back
Apoptosis
Front
Back
Cell injury
Front
Back
cell injury reversible with oxygen
Front
CELL/mitochondrial swelling (low ATP-> lower activity of Na+/K+ and Ca2+ pumps);
nuclear chromatin clumping, decreased glycogen, fatty change, ribosomal detachment (decrease protein synthesis)
Membrane blebbing
Back
Ischemia
Front
an inadequate blood supply to an organ or part of the body, especially the heart muscles.
Back
Apoptosis histology
Front
Deeply eosinophilic cytoplasm;
Basophilic nucleus
Pyknosis
Karyorhesis
Cell membrane typically remains intact (unlike necrosis)
DNA laddering (fragment in multiple of 180 bp) is a sensitive indicator
Back
fat necrosis due to
Front
Damaged cells release lipase to break down triglycerides, liberating fatty acids to bind Ca -> saponification
Back
Necrosis
Front
Enzymatic degradation and protein denaturation of cell due to exogenous injury -> intracellular components leak. Inflammatory process (unlike apoptosis)
Back
Karyorrhexis
Front
Fragmentation of nucleus
Caused by endonuclease-mediated cleavage
Back
wet gangrenous necrosis
Front
Superinfection
Back
caseous necrosis
Front
Back
Fas-FasL interaction
Front
Last way of killing for CD8+
(apoptosis) "death receptor", finishes up and marks for death
Thymic medullary negative selection
Back
coagulative necrosis
Front
Back
Gangrenous necrosis seen in
Front
Distal extremity and GI tract, after chronic ischemia
Back
Necrosis definition
Front
Death of a large group of cells followed by acute inflammation
Back
intrinsic pathway of apoptosis occurs
Front
occurs during embryogenesis, hormone induction, and atrophy
Regulating factor is withdrawn from a proliferating cell population (eg, decreased IL-2 after a completed immunologic reaction)
Also occurs after exposure to injurious stimuli (radiation, toxins, hypoxia)
autoimmune disease (extrinsic apoptotic pathway necessary for T cell negative selection)
Autoimmune lymphopriferative syndrome
Back
Section 2
(50 cards)
watershed areas of cerebral circulation
Front
Back
Red infarct
Front
Develops in tissues which have dual blood supplies (infarction)
Happens with lung infarction
Back
P-selectin
Front
derived from Weibel-Palade bodies in venular endothelial cells
Plateled and endothelial cells.
Step 1 leukocyte extravasation
Back
Pale infarct
Front
Occur in solid tissues with a single blood supply
Back
Cellular component of inflammation
Front
Neutrophils extravasate from circulation to injured tissue to participate in inflammation through phagocytosis, degranulation, and inflammatory mediator release
Back
pale infarct
Front
Anemic;
occur in solid tissues with SINGLE (end-arterial) blood supply like heart, kidney, spleen
Back
Extent of dystrophic calcification
Front
Tends to be localized (eg, calcific aortic stenosis) shows dystrophic calcification and thick fibrosis wall
Back
CD34, glyCAM-1
Front
addressin for L-selectin at lymph nodes
Back
VLA-4
Front
Expressed on activated T cells, guides T cells to site of infection by binding to VCAM-1
Back
ICAM-1
Front
- on APC or endothelium
- binds LFA-1 on T cell
CD54
Back
Sialyl-Lewis
Front
Adhesion molecules expressed on leukocytes that bind to selectins
Back
Most vulnerable neurons to hypoxic-ischemic insults
Front
Purkinje cells of cerebellum and pyramidal cells of the hypocampus and neocortex
Back
Etiology of dystrophic calcification
Front
2• to injury or necrosis
Back
metastatic calcification associated
Front
Predominantly in interstitial tissues of kidney, lung, gastric mucosa (these tissues lose acid quickly; increase pH favors Ca2+ deposition)
Nephrocalcinosis of collecting ducts May lead to nephrogenic diabetes insipidus and renal failure
Margination and rolling;
Tight binding (adhesion₽);
Diapedesis;
Migration
Back
Step 1 in leukocyte extravasation:
Front
Margination and rolling;
E-selectin; P-selection; GlyCAM-1; CD34;
Sialyl-LewisX leukocytes; L selectin.
Back
CD11/CD18
Front
markers for integrins
Back
Heart most vulnerable region to hypoxia/ischemia
Front
Subendocardium (LV)
Back
Liver most vulnerable region to hypoxia/ischemia
Front
Area around central vein (zone III)
Back
Chronic inflammation characteristics
Front
Persistent destruction and repair.
Associated with blood vessels proliferation, fibrosis. Granulomas.
Outcome include scarring, amyloidosis, and neoplastic transformation.
Back
VCAM-1
Front
Expressed on endothelium of blood vessels in inflamed tissue, binds to VLA-4 on T cells
CD106
Back
Dystrophic calcification Associate
Front
TB (lung, pericardium) and other granulomatous infection;
Liquefactive necrosis of chronic abscesses;
Fat necrosis;
Infarcts;
Thrombi;
Schistosomiasis;
Congenital CMV;
Toxoplasmosis;
Rubella;
Psamomma bodies;
CREST syndrome
Back
Psammoma bodies
Front
Meningiomas, papillary thyroid carc, mesothelioma, papillary serous carcinoma of endometrium/ovary
Back
metastatic calcification
Front
mineral deposits that occur in undamaged tissues due to hypercalcemia;
Widespread extent ( metastatic calcification of alveolar walls in acute pneumonia)
Back
watershed areas
Front
areas between terminal branches of major arterial blood supplies where blood supply does not overlap.
These areas are susceptible to ischemia from hypoperfusion
Back
Mac-1
Front
Integrin- heterodimer- one chain is CD18-the 2 integrin chain, on monocytes and macrophages
Back
Etiology of metastatic calcification
Front
2• to hypercalcemia (eg, 1• hyperparathyroidism; sarcoidosis; hypervitaminosis D)
or high calcium-phosphate product levels (eg, chronic renal failure with 2• hyperparathyroidism, long-term dialysis, calciihylaxis, multiple myeloma)
Back
Dystrophic calcification
Front
calcification of damaged tissue; normal serum calcium;
Extravasation predominantly occurs at postcapillary venules.
Back
acute inflammation cells
Front
Neutrophils, eosinophils, atb (pre-existing), mast cell, and basophil mediated.
Back
caseous necrosis histology
Front
Fragmented cells and debris surrounded by lymphocytes and macrophages
Back
E-selectin
Front
Selectin molecule on endothelial cells;
Unregulated by TNF and IL-1;
Step 1 of leukocyte extravasation.
Back
ACA
Front
anterior cerebral artery
Back
Serum Ca2+ levels in metastatic calcification
Front
Not normocalcemic
Back
Serum Ca2+ levels in patient with dystrophic calcification
Front
Normocalcemic
Back
Subsequent infarction in brain
Front
ACA/MCA/PCA boundary areas
Back
Acute inflammation characteristics
Front
Rapid onset (seconds, minutes) - short duration (minutes, days).
Outcome: complete resolution, abscess formation, or progression to chronic inflammation
Back
Granuloma
Front
Nodular collections of epithelioid macrophages (abundant pink cytoplasm) with surrounding multinucleated giant cells and lymphocytes.
Back
VCAM-1 and ICAM-1 aid in the (x) of leukocyte diapedesis
Front
Firm adhesion (x)
Back
LFA-1
Front
molecule expressed by leukocyte that assists in tight-binding stage of leukocyte extravasation
Back
Types of infarcts
Front
Red
Pale
Back
Margination and rolling is defective in which disorder(s)?
Front
Leukocyte adhesion deficiency type 2 (decreased Sialyl-Lewis)
Back
red infarct
Front
Hemorrhagic;
Occurs in venous occlusion and tissues with multiple blood supplies such as liver, lung, intestine, tested;
Reperfusion (after angioplasty) -> injury due to damage by free radicals
Back
Chronic inflammation cells
Front
Mononuclear cell (monocytes/macrophages, lymphocytes, plasma cells) and fibroblast mediated.
Back
Inflammation characterized by....
Front
redness (rubor), heat (calor), swelling (tumor), pain (dolor) and functio laesa (loss of function)
Back
Section 3
(50 cards)
Hypertrophic scar
Front
A raised scar characterized by excess collagen. (III)
Parallel organization of collagen
Confined to borders of original wound
Infrequent
No predisposition
Back
Sarcoidosis Dx
Front
Chest Xray, Lesion Biopsy ( Better sample is Lung. Do not take biopsy from erythema Nodosum)
Noncaseating granulomas
Back
ERBB1 (EGFR)
Front
Adenocarcinoma of Lung
Back
exudate
Front
cellular (cloudy), protein rich (>2.9 g/dL), high LDH (vs serum).
Due to:
lymphatic obstruction (chylous),
inflammation/infection;
malignancy.
Back
Granulomas formation
Front
Th1 cells secrete IFN-y, activating macrophages.
TNF-a from macrophages induces and maintains granuloma formation.
Associated with hypercalcemia due to calcitriol (1,25 -[OH]2 vitamin D3) production.
Caseating necrosis is more common with an infection etiology.
Back
VEGF
Front
stimulates angiogenesis
Back
Congo red stain
Front
Amyloid stains brick red and displays apple green birefringence with polarized light
Back
Autoinflammatory granulomatous disease
Front
Sarcoidosis
Crohn disease
Primary biliary cirrhosis
Subacute (de Quervain/granulomatous) thyroiditis
Granulomatosis with polyangiitis (Wegener)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Giant cell (temporal) arteritis
Takayasu arteritis
As a side effect can cause sequestering granulomas to break down, leading to disseminated disease.
Always test for Karen TB before starting anti-TNF therapy.
Back
Granulomatous disease from foreign material
Front
Berylliosis
Talcosis
Hypersensitivity pneumonitis
Back
Diapedesis is the
Front
migration of white blood cells from the blood out to the tissues.
Dx analysis comparing serum and pleural fluid protein and LDH levels.
Back
Amyloid deposits visualization by polarized light
Front
Apple-green birefringence
Back
effusion
Front
outpouring
Back
Amyloidosis
Front
Abnormal aggregation of proteins (or their fragments) into b-pleated linear sheets -> insoluble fibrils -> cellular damage and apoptosis.
Back
Pleural effusion is exudative if >= 1 of the following criteria is met:
Front
*Pleural effusion protein/serum ratio > 0.5
* Pleural effusion LDH/serum LDH ration > 0.6
* Pleural effusion LDH > 2/3 of the upper limit of normal for serum LDH
Back
PECAM-1
Front
CD31
Back
Oxygen toxicity examples
Front
Retinopathy of premature (abnormal vascularization), bronchopulmonary dysphasia, reperfusion injury after thrombolytic therapy
Back
remodeling phase of healing
Front
Fibroblasts
Type III collagen replaced by type I collagen,
Increase tensile strength of tissue.
Delayed wound healing in zinc deficiency.
Back
free radical injury
Front
damage to cells resulting from reactive oxygen species via:
Membrane lipid peroxidation;
Protein modification;
DNA breakage
Back
CHF (congestive heart failure)
Front
heart is unable to pump its required amount of blood
Back
Keloid scar
Front
Raised and moves beyond edges of wound (genetic and reoccurring)
Claw-like projection typically on earlobes, face, upper extremities.
Frequent reccurence.
Higher incidence in ethnic groups with darker skin,
Desorganized types I and III collagen
Back
Granulomas
Front
Back
Hypertrophic scar
Front
Back
Proliferative phase of healing characteristics:
Front
Deposition of granulation tissue and type III collagen, angiogenesis, epithelial cell proliferation, dissolution of clot, wound contraction (mediated by myofibroblasts).
Delayed wound healing in vit C deficiency and cooper deficiency.
Back
Free radicals can be eliminated by
Front
Scavenging enzymes (catalase, superoxide dismitase, glutathione peroxidase);
Spontaneous decay;
Antioxidants (A,C,E);
Certain metal carrier proteins (transferrin, ceruloplasmin).
Hypocellular (clear), poor protein (<2.5 g/dL), low LDH (vs serum).
Due to:
High hydrostatic pressure (eg, HF, Na+ retention)
Low oncotic pressure (eg, cirrhosis, nephrotic syndrome)
Back
Migration
Front
4 step of leukocyte extravasation.
WBC travels through interstitium to site of injury or infection guided by chemotaxis signals
Back
Erythrocytes sedimentation rate (ESR)
Front
Products of inflammation (eg, fibrinogen) coat RBCs and cause aggregation.
The denser RBC aggregates fall at a faster rate within a pipette tube.
Often co-tested with CRP levels.
Back
Tissue mediators
Front
PDGF, FGF, EGF, TGF-β, Metalloproteinases, VEGF
Back
C5a, IL8, LTB4, kallikrein, PAF
Front
important neutrophil chemotactic agents
Back
inflammatory phase of healing
Front
Platelets, neutrophils, macrophages;
Clot formation, increase vessel permeability and neutrophil migration into tissues;
Macrophages cleat debris 2 days later.
Back
Phase of wound healing:
Front
Inflammatory (up to 3 days after wound);
Proliferative (day 3-weeks after wound);
Remodeling (1 week-6+ months after wound)
Back
ROS drug/chemical toxicity:
Front
Carbon tetrachloride and acetaminophen overdose (hepatotoxicity)
Back
Keloid scar
Front
Back
high ESR
Front
Most anemias;
Infection;
Inflammation (eg, giant cell [temporal] arteritis, polymyalgia rheumatica);
Cancer (eg, metastases, multiple myeloma),
Renal Disease (end-stage or nephrotic syndrome);
Pregnancy
Back
Parasitic granulomatous disease
Front
Schistosomiasis
Back
Oxygen toxicity symptoms
Front
VENTIAC
V ertigo
E uphoria
N ausea
T innitus
I mpaired judgement
A LOC (Altered LOC)
C onvulsions
Back
Fungal granulomatous disease
Front
Endemic mycoses (eg, histoplasmosis)
Back
FGF
Front
Stimulates angiogenesis
Fibroblast growth factor
Back
PDGF
Front
Induces vascular remodeling and smooth muscle cell migration;
Stimulates fibroblast growth for collagen synthesis;
Secreted by activated platelets and macrophages.
Back
Amyloid deposits by H&E
Front
Back
Section 4
(50 cards)
Epithelial benign tumor
Front
Adenine, papilloma
Back
Hypertrophy
Front
Increase in cell size
Back
bone benign tumor
Front
osteoma
Back
Connective tissue benign tumor
Front
Fibroma
Back
Carcinoma
Front
a malignant tumor that occurs in epithelial tissue
Back
ESRD
Front
end-stage renal disease
Back
Heritable amyloidosis
Front
Heterogeneous group of disorders, including familial amyloid polyneuropathies due to transthyretin gene mutation.
Back
Hamartomas
Front
Disorganized overgrowth of tissue in their native location (eg, Peutz-Jeghers polyps)
Back
Neoplastic progression dysplasia
Front
Abnormal proliferation of cell with loss of size, shape, and orientation (eg, koilocytic change)
Back
Tumor Grading
Front
Stage generally has more prognostic value than grade
Back
Colon most vulnerable region to hypoxia/ischemia
Front
Splenic flexure, rectum
Back
AL amyloid (primary)
Front
Deposition of protein from Ig Light chains.
Can occur as a plasma cell disorder or associated with multiple myeloma.
Often affect multiple organ systems, including
renal (nephrotic syndrome),
cardiac (restrictive cardiomyopathy, arrhythmia),
hematologic (easy bruising, splenomegaly),
GI (hepatomegaly),
neurologic (neuropathy)
Back
poorly differentiated tumors
Front
recur more rapidly after diagnosis, higher short term mortality
Often more aggressive;
Look almost nothing like their tissue of origin
Back
blood vessels benign tumor
Front
hemangioma
Back
Hyperplasia
Front
increase in number of cells
May be a risk factor for future malignancy (eg, endometrial hyperplasia) but not considered premalignant.
Back
Choristoma
Front
normal tissue aberrant tissue location; pancreatic tissue stomach wall
Back
Tumor stage
Front
Degree of localization/spread based on site and size of 1• lesion, spread to regional lymph nodes, presence of metastases.
Based on clinical (c) or pathology (p) findings.
Back
invasive carcinoma
Front
Cells have invaded basement membrane using collagenases and hydrolases (metalloproteinases).
Cell-cell contacts lost by inactivation of E-cadherin.
Back
Neoplasia
Front
Uncontrolled, clonal proliferation of cells. Can be benign or malignant.
Back
metastasis
Front
spread to distant organs via lymphatics or blood.
Back
Epithelial malignancy
Front
Adenocarcinoma
Papillary carcinoma
Back
Atrophy
Front
Decrease in tissue mass due to decrease in size or/and number of cells.
Causes include disuse, denervation, loss of blood supply, loss of hormonal stimulation, poor nutrition.
Back
smooth muscle benign tumor
Front
leiomyoma
Back
Seed and soil theory
Front
Seed= tumor embolus
Soil = target organ is often the first-encountered capillary bed (liver, lungs, bone, brain, etc)
Back
Dialysis-related amyloidosis
Front
Fibrils composed of b2-microglobulin in patients with ESRD and/or long term dialysis.
May present as carpal tunnel syndrome.
Back
organ specific amyloidosis?
Front
Single organ;
Alzheimer disease due to deposition of b-amyloid protein cleaved from amyloid precursor protein (APP).
IAPP is commonly seen in DM2 and is caused by deposition of amylin in pancreatic islet.
Isolated atrial amyloidosis due to atrial natriuretic peptide is common in normal aging and can predispose to increased risk of atrial fibrillation.
Amyloid deposition to ventricular endomyocardium in restrictive cardiomyopathy.
Calcitonin deposition in tumor cells in medullary carcinoma of the thyroid.
Back
Kidney most vulnerable region to hypoxia/ischemia
Front
Straight segment of proximal tubule (medulla);
Thick ascending limb (medulla)
Back
Differentiation
Front
The degree to which a tumor resembles the normal tissue from which it arose
Back
fat benign tumor
Front
lipoma
Back
Malignant tumor
Front
Poor differentiation, erratic growth, local invasion, metastasis, decrease apoptosis.
Upregulation of telomerase prevents chromosome shortening and cell death.
Back
Peutz-Jeghers syndrome
Front
GI tract polyposis, mucocutaneous pigmentation
-estrogen secreting tumor: precocious puberty
Back
Metaplasia
Front
Replacement of one cell type with another.
Usually due to exposure to an irritant, such as gastric acid or cigarette smoke.
Reversible if the irritant is removed but may undergo malignant transformation with persistent insult (eg, Barrett esophagus-> esophageal adenocarcinoma)
Back
IAPP
Front
Islet amyloid polypeptide
Back
Koilocytes
Front
Seen in HPV. Dysplastic squamous cervical cells with nuclear enlargement and hyperchromasia
Back
AA amyloid (secondary)
Front
Seen with chronic inflammatory conditions such as RA, IBD, spondylarthropathy, familial Mediterranean fever, protracted infection.
Fibrils composed with serum Amyloid A.
Often multisystemic.
Back
Sarcoma
Front
Cancer of the supportive tissues (mesenchymal), such as bone, cartilage, and muscle.
Back
Non-neoplastic malformations:
Front
Hamartoma
Choristoma
Back
benign tumor
Front
Well differentiated, well demarcated, low mitotic activity, no metastasis, no necrosis.
Back
Anaplasia
Front
Complete lack of differentiation of cells in a malignant neoplasm
Back
Hallmarks of cancer
Front
Eight fundamental changes in cell biology that lead to malignant transformation:
Evasion of apoptosis;
Growth signal self-sufficiency;
Anti-growth Signal insensitivity;
Sustained angiogenesis;
Limitless replicative potential;
Tissue invasion;
Metastasis.
Back
Tumor grade
Front
Degree of cellular differentiation and mitotic activity on histology.
Range from low grade (well differentiated) to high grade (poorly differentiated, undifferentiated, anaplastic)
Back
Dysplasia
Front
Disordered cell growth, most often referring to proliferation of precancerous cells. Non-neoplastic cell growth.
Term used only with epithelial cells.
Mild dysplasia is usually reversible, severe dysplasia usually progresses to carcinoma in situ.
Back
Neoplastic progression: normal state, before anything goes wrong
Front
Normal cells w/ basal --< apical differentiation.
Back
carcinoma in situ
Front
noninvasive cancer located in a small area of the epithelial layer. Not invaded the intact basement membrane.
Increase nuclear: cytoplasmic ratio and clumped chromatin.
Neoplastic cells encompass entire thickness.
Back
Meckel's diverticulum
Front
Gastric tissue in distal ileum
Back
Well-differentiated tumors
Front
(often less aggressive) closely resemble their tissue of origin.
Back
TNM staging system
Front
T = size of T umor / invasiveness
N = N ode involvement
M = M etastases
Each TNM factor has independent prognostic value; N and M are often most important
Back
Lipofuscin
Front
A yellow-brown "wear and tear" pigment associated with normal aging.
Formed by oxidation and polymerization of autophagocytosed organellar membranes.
Autopsy of elderly person will reveal deposits in heart, colon, liver, kidney, eye, atc.
Back
Striated muscle benign tumor
Front
Rhabdomyoma
Back
Age-related (senile) systemic amyloidosis
Front
Due to deposition of normal ( wild-type) transthyretin (TTR) predominantly in cardiac ventricles.
Slower progression of cardiac dysfunction relative to AL amyloidosis.
Back
Section 5
(50 cards)
Cutaneous manifestation of paraneoplastic syndrome
Front
Acanthosis nigricans;
Sign of Leser-Trélat
Back
Anti-NMDA receptor encephalitis mechanism
Front
Psychiatric disturbance, memory deficits, seizures, dyskinesias, autonomic instability, language disfunction.
Back
blood vessels malignant tumor
Front
angiosarcoma
Back
bone malignant tumor
Front
osteosarcoma
Back
Endocrine manifestation of paraneoplastic syndrome
Tyrosine kinase receptor;
MEN2A and 2B, medullary thyroid cancer, and Hirschsprung's
Oncogene
Back
Arsenic
Front
Angiosarcoma (Liver)
lung cancer
squamous cell carcinoma (skin)
Back
CDKN2A - cyclin-dependent kinase inhibitor 2A
Front
encodes both P16 and P14 (blocks G1 ->S phase -> plays significant role in development of melanoma as well as SCC, pancreatic cancer
tumor suppressor genes
Tumor Suppressor (2 hit)
Pancreatic cancer
DPC—Deleted in Pancreatic Cancer
Back
TP53
Front
tumor suppressor gene
P53, activates p21, blocks G1->S phase
Most human cancers, Li-Fraumeni syndrome (multiple malignancies at early age)
Back
HHV-8
Front
Kaposi sarcoma
Back
Radon
Front
Lung cancer (2nd leading cause after cigarette smoke)
Back
Section 7
(22 cards)
Brain metastases
Front
50% of brain tumor are from metastases.
Commonly seen as multiple well-circumscribed tumors at gray/white matter junction.
Back
Liver metastasis
Front
Colon>>stomach>pancreas
Liver and lung are the most common sites of metastasis after the regional lymph nodes
Back
CEA
Front
carcinoembryonic antigen. Very nonspecific.
Major associations: colorectal and pancreatic cancers;
Minor associations: gastric, breast, medullary thyroid carcinomas.
Serum marker
Back
Calcitonin
Front
Medullary thyroid carcinoma
Alone and in MEN2A, MEN2B,
Serum marker
Back
Brain metastatic tumors are most likely from what?
Front
Lung tumors (40%) - often small cell, squamous, and adenocarcinoma in origin
Back
Bone metastases
Front
Prostate,breast > lung, thyroid, kidney.
>> 1• bone tumors (eg, multiple myeloma, lytic).
Breast (mixed)
Lung (lytic)
Thyroid (lytic)
Kidney (lytic)
Prostate (blastic)
Predilection for axial skeleton.
Back
CA 125 tumor marker
Front
Ovarian Cancer
Back
Alkaline phosphatase
Front
Metastases to bone, liver, Paget's disease of bone, seminoma (placental ALP)
Must exclude hepatic origin by checking LFTs and GGT levels
Back
cachexia
Front
Weight loss, muscle atrophy, fatigue that occur in chronic disease (cancer, AIDS, heart failure, COPD)
Mediated by TNF, IFN-y, IL-1, IL-6
Back
Brain metastatic tumors come from
Front
Lung > breast > melanoma, colon, kidney
Back
LFTs (Abbreviation)
Front
Liver Function Tests: AST, SGOT, ALT, SGPT
Back
a-fetoprotein
Front
Tumor marker seen in hepatocellular carcinomas and testicular cancers;
Hepatoblastoma,
Yolk sac (endodermal sinus) tumor, mixed germ cell tumor.
Back
CA 15-3/CA 27-29
Front
breast
Serum marker
Back
PSA
Front
prostate-specific antigen
Prostate cancer.
Can be elevated in BPH and prostatitis.
Surveillance marker for reccurence Disease after prostatectomy.
Back
Common metastases
Front
Most sarcomas spread hematogenously;
Most carcinomas spread via lymphatics. But 4! Hematogenously!
Follicular thyroid carcinoma, Choriocarcinoma, Renal cell carcinoma, Hepatocellular carcinoma.
Back
Chromogranin
Front
Neuroendocrine tumors/carcinoid
Serum marker
Back
B-hCG
Front
hydatiform mole, choriocarcinomas, gestational trophoblastic tumors, testicular cancer, mixed germ cell tumor.
Produced by syncytiotrophoblasts of the placenta
Back
a-fetoprotein (AFP)
Front
Normally made by fetus.
Transiently elevates in pregnancy.
High levels associated with neural tube and abdominal wall defects,
Low levels associated with Down syndrome
multi-drug resistant protein 1. Classically seen in adrenocortical carcinoma but also expressed in some cancer cells (colon, liver).
Used to pump out toxins, including chemotherapeutic agents (one mechanism of low responsiveness or resistance to Chemotherapy)